Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome

Contraception

Volumn 73, Issue 4, 2006, Pages 348-351

  Cagnacci, Angelo ^a,c   Tirelli, Alessandra ^a   Renzi, Antonietta ^a   Paoletti, Anna Maria ^b   Volpe, Annibale ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Contraceptive; Cyproterone acetate; Desogestrel; Homocysteine; Insulin sensitivity; Polycystic ovary syndrome

Indexed keywords

CYANOCOBALAMIN; DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE; FOLIC ACID; GLUCOSE; HOMOCYSTEINE; INSULIN; ORAL CONTRACEPTIVE AGENT;

ADULT; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; FEMALE; GLUCOSE UTILIZATION; HUMAN; INSULIN SENSITIVITY; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; CONTRACEPTIVES, ORAL; CYPROTERONE ACETATE; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INSULIN; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; VITAMIN B 12;

EID: 33644867982     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.09.011     Document Type: Article

References (27)

1. R. Azziz Diagnostic criteria for polycystic ovary syndrome: a reappraisal Fertil Steril 83 2005 1343 1345
2. F. Ovalle, and R. Azziz Insulin resistance, polycystic ovary syndrome and type 2 diabetes mellitus Fertil Steril 77 2002 1095 1105
3. C.J. Auerhammer, D. Ebgelhardt, and K.G. Parhofer Polycystic ovary syndrome and metabolic syndrome Dtsch Med Wochenschr 127 2002 971 977
4. G. Loverro, F. Lorusso, L. Mei, R. Depalo, G. Cormio, and L. Selvaggi The plasma homocysteine levels are increased in polycystic ovary syndrome Gynecol Obstet Invest 53 2002 157 162
5. E.J. Giltay, E.K. Hoogeveen, J.M. Elbers, L.J. Gooren, H. Asscheman, and C.D. Stehouerr Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects Atherosclerosis 139 1998 197 198
6. M.R. Nehler, L.M. Taylor, and J.M. Porter Homocysteinemia as a risk factor for atherosclerosis: a review Cardiovasc Surg 5 1997 559 567
7. J.S. Stamler, J.A. Osborne, and O. Jaraki Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen J Clin Invest 91 1993 308 318
8. A. Coppola, G. Davi, V. De Stefano, F.P. Mancini, A.M. Cerbone, and G. Di Minno Homocysteine coagulation, platelet function and thrombosis Semin Thromb Hemost 26 2000 243 254
9. C. Van Guldener, and C.D. Stehouwer Hyperhomocysteinemia vascular pathology and endothelial dysfunction Semin Thromb Hemost 26 2000 281 289
10. T.J. Green, L.A. Houghton, U. Donovan, R.S. Gibson, and D.L. O'Connor Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females J Am Diet Assoc 98 1998 49 55
11. G.S. Merki-Feld, B. Imthurn, and P.J. Keller Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine and lipid metabolism Metabolism 51 2002 1216 1221
12. A.M. Paoletti, A. Cagnacci, and R. Soldani Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome Fertil Steril 64 1995 1094 1098
13. S. Welch, S.S.P. Gebhart, R.N. Bergman, and L.S. Phillips Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects J Clin Endocrinol Metab 71 1990 1508 1518
14. A. Cagnacci, S. Arangino, A. Renzi, P. Cagnacci, and A. Volpe Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance test with different sampling frequency, oral glucose tolerance test or fasting Eur J Endocrinol 145 2001 281 287
15. O. Nygard, H. Refsum, P.M. Ueland, and S.E. Vollset Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study Am J Clin Nutr 67 1998 263 279
16. J. Scheede, H. Refsum, and P.M. Ueland Biological and environmental determinants of plasma homocysteine Semin Thromb Hemost 2000 263 279
17. M.F. Gursu, G. Bayadas, G. Cikim, and H. Canatan Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats Arch Med Res 33 2002 305 307
18. M.C. Audelin, and J. Genest Homocysteine and cardiovascular disease in diabetes mellitus Atherosclerosis 159 2001 497 511
19. W.H. Sheu, W.J. Lee, and J.T. Chen Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects Am J Hypertens 13 2000 14 20
20. H. Yarali, A. Yildinr, and F. Aybar Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome Fertil Steril 76 2001 511 516
21. M. Schachter, A. Raziel, S. Friedler, D. Strassburger, O. Bern, and R. Ron-El Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine Hum Reprod 18 2003 721 727
22. F. Bayraktar, D. Dereli, G. Ozgen, and C. Yilmaz Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia Endocr J 51 2004 601 608
23. E.S. Still, M.G. Genton, M. Perloe, G.L. Schattman, J.A. Bralley, and M.J. Tucker Plasma homocysteine, fasting insulin and androgen patterns among women with polycystic ovaries and infertility J Obstet Gynaecol Res 27 2001 163 168
24. F. Gonzalez, L. Chang, T. Horab, F. Stanczyk, K. Crickard, and R. Lobo Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome Fertil Steril 71 1999 439 444
25. American Diabetes Association Consensus Development Conference on Insulin Resistance; 5-6 November 1997 Diabetes Care 21 1998 310 314
26. J.E. Foley, Y.D. Chen, C.K. Lardinois, C.B. Hollenbeck, G.C. Liu, and G.M. Reaven Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniques Horm Metab Res 17 1985 406 409
27. A. Cagnacci, A.M. Paoletti, and A. Renzi Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel J Clin Endocrinol Metab 88 2003 3621 3625